health
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
TL;DR
- Founders in healthcare must adapt to longer timelines and higher stakes, requiring rigor over speed.
- BioticsAI is developing an AI copilot for ultrasound to detect fetal abnormalities.
- The company built an early prototype for under $100,000 and won TechCrunch Startup Battlefield in 2023.
- BioticsAI integrated product development, clinical validation, and regulatory strategy from day one.
- Early engagement with FDA regulators through pre-submission meetings was crucial.
- Motivating the team during long development cycles involved fostering alignment and celebrating R&D wins.
- BioticsAI has secured FDA approval and plans to expand its technology beyond obstetrics into reproductive health.